Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

SAR-439883 rescues memory deficits and prevents neurodegeneration in animal models of AD

Nov. 3, 2021

Disarm Therapeutics discloses SARM1 inhibitors

Nov. 2, 2021

Researchers recapitulate anti-NMDA receptor encephalitis in zebrafish

Nov. 2, 2021

Gene therapy provides pain relief by resetting "corrupted" circuit

Oct. 29, 2021

Researchers develop a novel rotenone-induced murine model of bipolar disorder

Oct. 29, 2021

IACTA Pharmaceuticals receives funding to conduct preclinical studies of IC-800

Oct. 29, 2021

Novel AChE/GSK-3beta inhibitor shows promising activity in models of AD

Oct. 29, 2021

CD300a blockade ameliorates neuronal deficit after ischemic stroke

Oct. 29, 2021

THAP1 gene variation associated with neurodevelopmental disorders and impaired myelination

Oct. 29, 2021

CXCR4-CXCL12 signaling axis as therapeutic target for Lewy body dementia

Oct. 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...